Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 592)
Posted On: 06/20/2022 12:40:29 PM
Post# of 156193
Posted By: Plotinus
Re: Emmitt #125074
Breakthrough therapy worthy also; septic shock has a 40% mortality rate. For impact if I were designing the trial I would be tempted to limit it to ED venue and code sepsis. They are prepared for rapid response, stat labs (lactate levels might be part of inclusion criteria), IV route etc and you avoid mild/moderate cases. Move the needle on mortality rate and that is breakthrough.













(9)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site